XML 8 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Investments, at fair value    
Investments, at fair value $ 1,563,343 $ 1,582,075
Cash and cash equivalents 6,743 7,780
Restricted cash and cash equivalents 25,205 16,690
Interest and dividend receivable 14,774 14,000
Receivable from unsettled transactions 2,782 251
Unrealized appreciation on foreign currency forward contracts 4,713 5,128
Deferred tax assets 787 114
Other assets 2,022 1,341
Total assets 1,620,369 1,627,379
Liabilities    
Debt (net of deferred financing costs of $6,621 and $7,138, respectively) 831,426 844,783
Distributions payable 15,195 15,195
Interest and other debt financing costs payable 8,734 10,900
Management fees payable 4,942 5,026
Incentive fees payable 4,901 4,770
Deferred tax liabilities 912 578
Unrealized depreciation on foreign currency forward contracts 26 84
Accrued expenses and other liabilities 2,535 3,449
Total liabilities 868,671 884,785
Commitments and Contingencies (Note 8)
Net assets    
Common stock, par value $0.001 per share (200,000,000 shares authorized, 37,061,547 shares issued and outstanding) 37 37
Paid-in capital in excess of par value 965,895 965,895
Accumulated earnings (loss) (214,234) (223,338)
Total net assets 751,698 742,594
Total liabilities and net assets $ 1,620,369 $ 1,627,379
Net asset value per share $ 20.28 $ 20.04
Non-controlled non-affiliated    
Investments, at fair value    
Investments, at fair value $ 1,451,357 $ 1,465,537
Non-controlled affiliated    
Investments, at fair value    
Investments, at fair value 50,618 52,619
Controlled    
Investments, at fair value    
Investments, at fair value $ 61,368 $ 63,919